Literature DB >> 26437303

Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain.

Kristof Deseure1, Guy H Hans2.   

Abstract

Animal models are important tools to study the pathophysiology and pharmacology of neuropathic pain. This manuscript describes the surgical and behavioral procedures to study trigeminal neuropathic pain in rats. To meet the specificity of trigeminal neuropathic pain syndromes, the infraorbital nerve (IoN) is subjected to a chronic constriction injury (CCI) by loosely ligating the nerve. An intra-orbital approach is presented here to expose and ligate the IoN in the orbital cavity. After IoN ligation, rats exhibit changes in spontaneous behavior and in response to von Frey hair stimulation that are indicative of persistent pain and mechanical allodynia. Two phases can be defined in the development of the behavioral changes. During the first week following IoN-CCI (phase 1), rats show an increased and asymmetric face grooming activity, i.e., with face wash strokes primarily directed to the nerve-injured IoN territory. A distinction is made between face grooming behavior that is part of a more general body grooming behavior, which remains largely unaffected by IoN-CCI, and face grooming that is neither preceded nor followed by body grooming, which is significantly increased after IoN-CCI. During this period, responsiveness to mechanical stimulation of the IoN territory is reduced. This hyporesponsiveness is abruptly replaced by an extreme hyperresponsiveness whereby even very weak stimulus intensities provoke nocifensive behavior (phase 2). The phenomenological similarities between these behavioral alterations and reported signs of facial pain (i.e., responses to noxious stimulation of the face) suggest the presence of dysesthesia/paresthesia and mechanical allodynia in the ligated IoN territory.

Entities:  

Mesh:

Year:  2015        PMID: 26437303      PMCID: PMC4692620          DOI: 10.3791/53167

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

1.  Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.

Authors:  Kristof Deseure; Wouter Koek; Hugo Adriaensen; Francis C Colpaert
Journal:  J Pharmacol Exp Ther       Date:  2003-05-02       Impact factor: 4.030

Review 2.  What should we be measuring in behavioral studies of chronic pain in animals?

Authors:  Jeffrey S Mogil; Sara E Crager
Journal:  Pain       Date:  2004-11       Impact factor: 6.961

3.  Meal duration as a measure of orofacial nociceptive responses in rodents.

Authors:  Phillip R Kramer; Larry L Bellinger
Journal:  J Vis Exp       Date:  2014-01-10       Impact factor: 1.355

4.  Application of the formalin test to the study of orofacial pain in the rat.

Authors:  P Clavelou; J Pajot; R Dallel; P Raboisson
Journal:  Neurosci Lett       Date:  1989-09-11       Impact factor: 3.046

Review 5.  The clinical picture of neuropathic pain.

Authors:  T S Jensen; H Gottrup; S H Sindrup; F W Bach
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

6.  Behavioral study of non-evoked orofacial pain following different types of infraorbital nerve injury in rats.

Authors:  Kristof Deseure; Guy Hans
Journal:  Physiol Behav       Date:  2014-10-24

7.  Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve.

Authors:  B P Vos; A M Strassman; R J Maciewicz
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

8.  Characterization of bilateral trigeminal constriction injury using an operant facial pain assay.

Authors:  H L Rossi; A C Jenkins; J Kaufman; I Bhattacharyya; R M Caudle; J K Neubert
Journal:  Neuroscience       Date:  2012-08-19       Impact factor: 3.590

9.  Nonevoked facial pain in rats following infraorbital nerve injury: a parametric analysis.

Authors:  Kristof Deseure; Hugo Adriaensen
Journal:  Physiol Behav       Date:  2004-06

10.  Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs.

Authors:  Juliana Geremias Chichorro; Aleksander Roberto Zampronio; Gloria Emilia Petto Souza; Giles Alexander Rae
Journal:  Pain       Date:  2006-03-24       Impact factor: 6.961

View more
  9 in total

1.  Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABAA receptors.

Authors:  Dina Vasović; Branka Divović; Marco Treven; Daniel E Knutson; Friederike Steudle; Petra Scholze; Aleksandar Obradović; Jure Fabjan; Božidar Brković; Werner Sieghart; Margot Ernst; James M Cook; Miroslav M Savić
Journal:  Eur J Pain       Date:  2019-02-04       Impact factor: 3.931

2.  Pain Relief in a Trigeminal Neuralgia Model via Optogenetic Inhibition on Trigeminal Ganglion Itself With Flexible Optic Fiber Cannula.

Authors:  Elina Kc; Jaisan Islam; Soochong Kim; Hyong Kyu Kim; Young Seok Park
Journal:  Front Cell Neurosci       Date:  2022-04-28       Impact factor: 6.147

3.  When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Authors:  Jill M Pulley; Rebecca N Jerome; Nicole M Zaleski; Jana K Shirey-Rice; Andrea J Pruijssers; Robert R Lavieri; Somsundaram N Chettiar; Helen M Naylor; David M Aronoff; David A Edwards; Colleen M Niswender; Laura L Dugan; Leslie J Crofford; Gordon R Bernard; Kenneth J Holroyd
Journal:  Assay Drug Dev Technol       Date:  2017-12-01       Impact factor: 1.738

4.  Effects of long non-coding RNA Gm14461 on pain transmission in trigeminal neuralgia.

Authors:  Mu Xu; Yi Yan; Mengye Zhu; Zhijian Wang; Xuexue Zhang; Daying Zhang
Journal:  J Inflamm (Lond)       Date:  2020-01-03       Impact factor: 4.981

5.  TRESK alleviates trigeminal neuralgia induced by infraorbital nerve chronic constriction injury in rats.

Authors:  Yuanyuan Li; Hena Jiao; Wenan Ren; Fei Ren
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic pain.

Authors:  Chirag Vasavda; Risheng Xu; Jason Liew; Ruchita Kothari; Ryan S Dhindsa; Evan R Semenza; Bindu D Paul; Dustin P Green; Mark F Sabbagh; Joseph Y Shin; Wuyang Yang; Adele M Snowman; Lauren K Albacarys; Abhay Moghekar; Carlos A Pardo-Villamizar; Mark Luciano; Judy Huang; Chetan Bettegowda; Shawn G Kwatra; Xinzhong Dong; Michael Lim; Solomon H Snyder
Journal:  Sci Adv       Date:  2022-08-03       Impact factor: 14.957

7.  Olfactory Ensheathing Cells Alleviate Facial Pain in Rats with Trigeminal Neuralgia by Inhibiting the Expression of P2X7 Receptor.

Authors:  Jiafeng Lu; Baolin Yang; Jiayi Liao; Baokang Chen; Mingxin Lu; Wenjun Zhang; Jingnan Zeng; Hui Cheng; Zengxu Liu
Journal:  Brain Sci       Date:  2022-05-30

8.  Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model.

Authors:  Chiara Demartini; Rosaria Greco; Anna Maria Zanaboni; Oscar Francesconi; Cristina Nativi; Cristina Tassorelli; Kristof Deseure
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

9.  Trigeminal neuropathic pain causes changes in affective processing of pain in rats.

Authors:  Erika I Araya; Eduardo C Carvalho; Roberto Andreatini; Gerald W Zamponi; Juliana G Chichorro
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.